<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="generate">
            <roleset id="generate.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="agent, causer&#x09;&#x09;//gene, process//&#x0A;" />
                    <role n="1" descr="thing created&#x09;&#x09;&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A transcription start site is located approximately 4 kilobases 5 to the translation codon, and an RNA splice of 3863 bases occurring in the 5-untranslated region generated mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A transcription start site is located approximately 4 kilobases 5 to the translation codon, and an RNA splice of 3863 bases occurring in the 5-untranslated region generates mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>A transcription start site is located approximately 4 kilobases 5 to the translation codon, and mature HeLa cell mRNA has been generated by an RNA splice of 3863 bases occurring in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>A transcription start site is located approximately 4 kilobases 5 to the translation codon, and mature HeLa cell mRNA is generated by an RNA splice of 3863 bases occurring in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>A transcription start site is located approximately 4 kilobases 5 to the translation codon, and mature HeLa cell mRNA was generated by an RNA splice of 3863 bases occurring in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>A transcription start site is located approximately 4 kilobases 5 to the translation codon, and mature HeLa cell mRNA will be generated by an RNA splice of 3863 bases occurring in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Abeta peptides can be generated from proteolysis of the amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Abeta peptides have been generated from proteolysis of the amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Abeta peptides were generated from proteolysis of the amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that L723 in H3 generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that L723 in H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that the correct three-dimensional interaction surface has been generated by L723 in H3</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that the correct three-dimensional interaction surface is generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that the correct three-dimensional interaction surface was generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that the correct three-dimensional interaction surface will be generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Human leukocyte antigen (HLA)-G molecules have been generated by an alternative splicing of the primary transcript of the gene and have displayed specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Human leukocyte antigen (HLA)-G molecules were generated by an alternative splicing of the primary transcript of the gene and displayed specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>Human leukocyte antigen (HLA)-G molecules will be generated by an alternative splicing of the primary transcript of the gene and will display specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>In addition, the AR N-terminus generated a functional interaction surface, since its deletion abolished FHL2 binding.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>In addition, the AR N-terminus generates a functional interaction surface, since its deletion abolishes FHL2 binding.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>In addition, the AR N-terminus, whose deletion abolishes FHL2 binding, generates a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>In addition, the AR N-terminus, whose deletion had abolished FHL2 binding, generated a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of degradation, although again the relatively small fraction involved and the possibility that degradation did not generate specific fragments or occured rapidly precludes any definitive conclusions</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of degradation, although again the relatively small fraction involved and the possibility that specific fragments are not generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of degradation, although again the relatively small fraction involved and the possibility that specific fragments have not been generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of degradation, although again the relatively small fraction involved and the possibility that specific fragments were not generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of degradation, although again the relatively small fraction involved and the possibility that specific fragments will not be generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>In the absence of L-arginine, nNOS generated superoxide (O(2)-).</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>In the absence of L-arginine, nNOS generates superoxide (O(2)-).</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>In the absence of L-arginine, superoxide (O(2)-) has been generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>In the absence of L-arginine, superoxide (O(2)-) is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>In the absence of L-arginine, superoxide (O(2)-) was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>In the absence of L-arginine, superoxide (O(2)-) will be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>Major transcripts of 1.7 and 2.7 kb are generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>Major transcripts of 1.7 and 2.7 kb were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>NO reacts anaerobically with the Fe-S cluster of purified FNR generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>NO reacts anaerobically with the Fe-S cluster of purified FNR generated spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>Prnd can generate major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>Prnd generated major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>Prnd generates major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>Prnd is able to generate major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>Sequential overlapping fragments are generated by The TBC method ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>Sequential overlapping fragments were generated by The TBC method ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a have been generated by mutating amino acids EE (437 and 438) to AA.FLAG epitope has been added to the C-terminus of Stat5aEE-AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mutating amino acids EE (437 and 438) to AA.FLAG epitope is added to the C-terminus of Stat5aEE-AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a will be generated by mutating amino acids EE (437 and 438) to AA.FLAG epitope will be added to the C-terminus of Stat5aEE-AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>The TBC method generated sequential overlapping fragments ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>The TBC method generates sequential overlapping fragments ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>The TBC method has generated sequential overlapping fragments ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>The TBC method may generate sequential overlapping fragments ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>The bidentate RNase III Dicer generated the 21-23 nt long mature RNAs.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The bidentate RNase III Dicer generates the 21-23 nt long mature RNAs.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>The bidentate RNase III Dicer has generated the 21-23 nt long mature RNAs.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>The bidentate RNase III Dicer is able to generate the 21-23 nt long mature RNAs.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>These are fumarate reductase (encoded by the frdABCD operon), fumarase B, which generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>These are fumarate reductase (encoded by the frdABCD operon), fumarase B, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>These are fumarate reductase (encoded by the frdABCD operon), fumarase B, which will generate fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>To analyse specifically protein expression of FHL2 in human tissues we may generate a monoclonal antibody against FHL2.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, a monoclonal antibody against FHL2 is generated by us</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, a monoclonal antibody against FHL2 was generated by us</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, we generate a monoclonal antibody against FHL2.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, we will generate a monoclonal antibody against FHL2.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>We believe this binding is found to generate a higher order protein-DNA complex within the recombinational synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>We believe this binding is shown to generate a higher order protein-DNA complex within the recombinational synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>We report results from preliminary transcription microarray experiments that revealed two previously unknown members of the NarL regulon: the aspA gene encoding aspartate-ammonia lyase being able to generate fumarate; and the dcuSR operon encoding the dicarboxylate-responsive regulatory system.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>We report results from preliminary transcription microarray experiments that revealed two previously unknown members of the NarL regulon: the aspA gene encoding aspartate-ammonia lyase generating fumarate; and the dcuSR operon encoding the dicarboxylate-responsive regulatory system.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>We report results from preliminary transcription microarray experiments that revealed two previously unknown members of the NarL regulon: the aspA gene encoding aspartate-ammonia lyase which generates fumarate; and the dcuSR operon encoding the dicarboxylate-responsive regulatory system.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>We report results from preliminary transcription microarray experiments that revealed two previously unknown members of the NarL regulon: the aspA gene encoding aspartate-ammonia lyase which has generated fumarate; and the dcuSR operon encoding the dicarboxylate-responsive regulatory system.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>a DNase I hypersensitive is generated by a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>a DNase I hypersensitive was generated by a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generate a DNase I hypersensitive.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generated a DNase I hypersensitive.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>a functional interaction surface is generated by the AR N-terminus whose deletion abolishes FHL2 binding.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>a functional interaction surface was generated by the AR N-terminus, because the AR N-terminuss deletion abolishes FHL2 binding.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>a higher order protein-DNA complex is generated by this binding within the recombinational synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>a higher order protein-DNA complex was generated by this binding within the recombinational synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>an alternative splicing of the primary transcript of the gene generated Human leukocyte antigen (HLA)-G molecules.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>an alternative splicing of the primary transcript of the gene generates Human leukocyte antigen (HLA)-G molecules.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>fumarate (from malate, and the DcuB permease for fumarate, malate, and aspartate) are generated by fumarase B.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>fumarate (from malate, and the DcuB permease for fumarate, malate, and aspartate) were generated by fumarase B.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>intergenic splicing with Prnp generate some unusual chimeric transcripts.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>intergenic splicing with Prnp has generated some unusual chimeric transcripts.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>mutating amino acids EE (437 and 438) to AA are able to generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.FLAG epitope was added to the C-terminus of Stat5aEE-AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>mutating amino acids EE (437 and 438) to AA can generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.FLAG epitope was added to the C-terminus of Stat5aEE-AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>mutating amino acids EE (437 and 438) to AA generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a.FLAG epitope was added to the C-terminus of Stat5aEE-AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>mutating amino acids EE (437 and 438) to AA generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a.FLAG epitope was added to the C-terminus of Stat5aEE-AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>proteolysis of the amyloid precursor proteins (APP) generate Abeta peptides.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>proteolysis of the amyloid precursor proteins (APP) generated Abeta peptides.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>some unusual chimeric transcripts are generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>some unusual chimeric transcripts have been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>some unusual chimeric transcripts may be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="91">
                    <text>some unusual chimeric transcripts were generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="92">
                    <text>some unusual chimeric transcripts will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="93">
                    <text>spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex are generated by NO reacts anaerobically with the Fe-S cluster of purified FNR.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="EGRAM" no="94">
                    <text>spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex were generated by NO reacts anaerobically with the Fe-S cluster of purified FNR.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="EGRAM" no="95">
                    <text>the 21-23 nt long mature RNAs are generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="EGRAM" no="96">
                    <text>the 21-23 nt long mature RNAs were generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="EGRAM" no="97">
                    <text>this binding generated a higher order protein-DNA complex within the recombinational synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="EGRAM" no="98">
                    <text>this binding generates a higher order protein-DNA complex within the recombinational synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
